nodes	percent_of_prediction	percent_of_DWPC	metapath
Metoclopramide—migraine—Prednisone—Crohn's disease	0.911	1	CpDpCtD
Metoclopramide—HTR3A—enteric nervous system—Crohn's disease	0.0247	0.514	CbGeAlD
Metoclopramide—HTR3A—myenteric nerve plexus—Crohn's disease	0.0187	0.389	CbGeAlD
Metoclopramide—Sunitinib—LRRK2—Crohn's disease	0.00214	0.298	CrCbGaD
Metoclopramide—CYP11B2—lymph node—Crohn's disease	0.00169	0.0351	CbGeAlD
Metoclopramide—Sunitinib—JAK2—Crohn's disease	0.00163	0.226	CrCbGaD
Metoclopramide—Sunitinib—TYK2—Crohn's disease	0.00163	0.226	CrCbGaD
Metoclopramide—HTR3A—digestive system—Crohn's disease	0.00142	0.0295	CbGeAlD
Metoclopramide—CYP17A1—lymph node—Crohn's disease	0.00103	0.0215	CbGeAlD
Metoclopramide—Procainamide—SLC22A4—Crohn's disease	0.00102	0.142	CrCbGaD
Metoclopramide—Procainamide—SLC22A5—Crohn's disease	0.000769	0.107	CrCbGaD
Metoclopramide—Hepatotoxicity—Mercaptopurine—Crohn's disease	0.000653	0.059	CcSEcCtD
Metoclopramide—CYP2D6—digestive system—Crohn's disease	0.000521	0.0108	CbGeAlD
Metoclopramide—Hepatotoxicity—Azathioprine—Crohn's disease	0.000389	0.0352	CcSEcCtD
Metoclopramide—Hepatotoxicity—Mesalazine—Crohn's disease	0.000354	0.032	CcSEcCtD
Metoclopramide—Blood disorder—Mesalazine—Crohn's disease	0.000327	0.0296	CcSEcCtD
Metoclopramide—Delirium—Mesalazine—Crohn's disease	0.000318	0.0288	CcSEcCtD
Metoclopramide—Amenorrhoea—Mesalazine—Crohn's disease	0.000311	0.0282	CcSEcCtD
Metoclopramide—Menstruation irregular—Prednisone—Crohn's disease	0.000261	0.0236	CcSEcCtD
Metoclopramide—Atrial fibrillation—Mesalazine—Crohn's disease	0.00021	0.019	CcSEcCtD
Metoclopramide—Renal impairment—Mesalazine—Crohn's disease	0.000209	0.0189	CcSEcCtD
Metoclopramide—Suicidal ideation—Prednisone—Crohn's disease	0.000206	0.0187	CcSEcCtD
Metoclopramide—Mania—Prednisone—Crohn's disease	0.000199	0.018	CcSEcCtD
Metoclopramide—Leukopenia—Mercaptopurine—Crohn's disease	0.000197	0.0178	CcSEcCtD
Metoclopramide—Oedema—Mercaptopurine—Crohn's disease	0.00018	0.0163	CcSEcCtD
Metoclopramide—Asthma—Mesalazine—Crohn's disease	0.000172	0.0155	CcSEcCtD
Metoclopramide—Bronchospasm—Mesalazine—Crohn's disease	0.000169	0.0153	CcSEcCtD
Metoclopramide—Delirium—Prednisone—Crohn's disease	0.000168	0.0152	CcSEcCtD
Metoclopramide—Amenorrhoea—Prednisone—Crohn's disease	0.000165	0.0149	CcSEcCtD
Metoclopramide—Neutropenia—Mesalazine—Crohn's disease	0.00016	0.0145	CcSEcCtD
Metoclopramide—Pollakiuria—Mesalazine—Crohn's disease	0.000159	0.0143	CcSEcCtD
Metoclopramide—Agranulocytosis—Azathioprine—Crohn's disease	0.000157	0.0142	CcSEcCtD
Metoclopramide—Depression—Mesalazine—Crohn's disease	0.000153	0.0138	CcSEcCtD
Metoclopramide—Jaundice—Mesalazine—Crohn's disease	0.000149	0.0135	CcSEcCtD
Metoclopramide—Agranulocytosis—Mesalazine—Crohn's disease	0.000143	0.0129	CcSEcCtD
Metoclopramide—Body temperature increased—Mercaptopurine—Crohn's disease	0.000142	0.0129	CcSEcCtD
Metoclopramide—Fluid retention—Prednisone—Crohn's disease	0.000137	0.0124	CcSEcCtD
Metoclopramide—Hypersensitivity—Mercaptopurine—Crohn's disease	0.000132	0.012	CcSEcCtD
Metoclopramide—Diarrhoea—Mercaptopurine—Crohn's disease	0.000123	0.0111	CcSEcCtD
Metoclopramide—Leukopenia—Azathioprine—Crohn's disease	0.000117	0.0106	CcSEcCtD
Metoclopramide—Nervousness—Mesalazine—Crohn's disease	0.000116	0.0105	CcSEcCtD
Metoclopramide—Cardiac failure congestive—Prednisone—Crohn's disease	0.000116	0.0105	CcSEcCtD
Metoclopramide—Muscle spasms—Mesalazine—Crohn's disease	0.000115	0.0104	CcSEcCtD
Metoclopramide—Rash—Mercaptopurine—Crohn's disease	0.000113	0.0103	CcSEcCtD
Metoclopramide—Dermatitis—Mercaptopurine—Crohn's disease	0.000113	0.0102	CcSEcCtD
Metoclopramide—Tremor—Mesalazine—Crohn's disease	0.000112	0.0101	CcSEcCtD
Metoclopramide—Angioedema—Mesalazine—Crohn's disease	0.000109	0.00988	CcSEcCtD
Metoclopramide—Leukopenia—Mesalazine—Crohn's disease	0.000107	0.00968	CcSEcCtD
Metoclopramide—Nausea—Mercaptopurine—Crohn's disease	0.000107	0.00966	CcSEcCtD
Metoclopramide—Palpitations—Mesalazine—Crohn's disease	0.000106	0.00956	CcSEcCtD
Metoclopramide—Hypertension—Mesalazine—Crohn's disease	0.000103	0.00934	CcSEcCtD
Metoclopramide—Anxiety—Mesalazine—Crohn's disease	0.000101	0.00918	CcSEcCtD
Metoclopramide—Hypotension—Azathioprine—Crohn's disease	0.0001	0.00906	CcSEcCtD
Metoclopramide—Cardiac arrest—Prednisone—Crohn's disease	9.99e-05	0.00904	CcSEcCtD
Metoclopramide—Confusional state—Mesalazine—Crohn's disease	9.84e-05	0.0089	CcSEcCtD
Metoclopramide—Oedema—Mesalazine—Crohn's disease	9.76e-05	0.00883	CcSEcCtD
Metoclopramide—Tachycardia—Mesalazine—Crohn's disease	9.52e-05	0.00862	CcSEcCtD
Metoclopramide—Hypotension—Mesalazine—Crohn's disease	9.12e-05	0.00825	CcSEcCtD
Metoclopramide—Feeling abnormal—Azathioprine—Crohn's disease	8.83e-05	0.00799	CcSEcCtD
Metoclopramide—Insomnia—Mesalazine—Crohn's disease	8.83e-05	0.00799	CcSEcCtD
Metoclopramide—Dyspnoea—Mesalazine—Crohn's disease	8.7e-05	0.00787	CcSEcCtD
Metoclopramide—Somnolence—Mesalazine—Crohn's disease	8.67e-05	0.00785	CcSEcCtD
Metoclopramide—Neutropenia—Prednisone—Crohn's disease	8.49e-05	0.00768	CcSEcCtD
Metoclopramide—Body temperature increased—Azathioprine—Crohn's disease	8.47e-05	0.00766	CcSEcCtD
Metoclopramide—Fatigue—Mesalazine—Crohn's disease	8.41e-05	0.00761	CcSEcCtD
Metoclopramide—Erectile dysfunction—Prednisone—Crohn's disease	8.36e-05	0.00757	CcSEcCtD
Metoclopramide—Depression—Prednisone—Crohn's disease	8.07e-05	0.0073	CcSEcCtD
Metoclopramide—Feeling abnormal—Mesalazine—Crohn's disease	8.04e-05	0.00728	CcSEcCtD
Metoclopramide—HTR4—Signaling Pathways—RSPO3—Crohn's disease	7.98e-05	0.00355	CbGpPWpGaD
Metoclopramide—Hypersensitivity—Azathioprine—Crohn's disease	7.89e-05	0.00714	CcSEcCtD
Metoclopramide—HTR3A—SIDS Susceptibility Pathways—IL1B—Crohn's disease	7.84e-05	0.00349	CbGpPWpGaD
Metoclopramide—DRD2—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	7.78e-05	0.00346	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—CCR6—Crohn's disease	7.76e-05	0.00345	CbGpPWpGaD
Metoclopramide—Urticaria—Mesalazine—Crohn's disease	7.75e-05	0.00701	CcSEcCtD
Metoclopramide—DRD3—GPCR ligand binding—GPR65—Crohn's disease	7.75e-05	0.00345	CbGpPWpGaD
Metoclopramide—Body temperature increased—Mesalazine—Crohn's disease	7.71e-05	0.00698	CcSEcCtD
Metoclopramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	7.62e-05	0.00339	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—SEL1L—Crohn's disease	7.56e-05	0.00336	CbGpPWpGaD
Metoclopramide—HTR4—GPCR downstream signaling—PTGER4—Crohn's disease	7.52e-05	0.00335	CbGpPWpGaD
Metoclopramide—DRD3—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	7.45e-05	0.00331	CbGpPWpGaD
Metoclopramide—Bradycardia—Prednisone—Crohn's disease	7.4e-05	0.00669	CcSEcCtD
Metoclopramide—Diarrhoea—Azathioprine—Crohn's disease	7.33e-05	0.00663	CcSEcCtD
Metoclopramide—DRD3—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	7.25e-05	0.00322	CbGpPWpGaD
Metoclopramide—Hallucination—Prednisone—Crohn's disease	7.23e-05	0.00654	CcSEcCtD
Metoclopramide—Hypersensitivity—Mesalazine—Crohn's disease	7.19e-05	0.0065	CcSEcCtD
Metoclopramide—Dizziness—Azathioprine—Crohn's disease	7.08e-05	0.00641	CcSEcCtD
Metoclopramide—CYP11B1—Metabolism—PLA2G4F—Crohn's disease	7.03e-05	0.00313	CbGpPWpGaD
Metoclopramide—Asthenia—Mesalazine—Crohn's disease	7e-05	0.00633	CcSEcCtD
Metoclopramide—DRD2—G alpha (i) signalling events—CCR6—Crohn's disease	6.98e-05	0.0031	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—MTMR3—Crohn's disease	6.94e-05	0.00309	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—CCR9—Crohn's disease	6.92e-05	0.00308	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—PTGER4—Crohn's disease	6.83e-05	0.00304	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—MLN—Crohn's disease	6.79e-05	0.00302	CbGpPWpGaD
Metoclopramide—Rash—Azathioprine—Crohn's disease	6.75e-05	0.00611	CcSEcCtD
Metoclopramide—Dermatitis—Azathioprine—Crohn's disease	6.75e-05	0.00611	CcSEcCtD
Metoclopramide—Flushing—Prednisone—Crohn's disease	6.74e-05	0.0061	CcSEcCtD
Metoclopramide—Headache—Azathioprine—Crohn's disease	6.71e-05	0.00607	CcSEcCtD
Metoclopramide—Diarrhoea—Mesalazine—Crohn's disease	6.68e-05	0.00604	CcSEcCtD
Metoclopramide—CYP17A1—Metabolism—PLA2G4F—Crohn's disease	6.58e-05	0.00293	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—ACKR2—Crohn's disease	6.51e-05	0.0029	CbGpPWpGaD
Metoclopramide—DRD2—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	6.47e-05	0.00288	CbGpPWpGaD
Metoclopramide—Dizziness—Mesalazine—Crohn's disease	6.45e-05	0.00584	CcSEcCtD
Metoclopramide—HTR4—Signaling Pathways—GPR65—Crohn's disease	6.43e-05	0.00286	CbGpPWpGaD
Metoclopramide—HTR4—GPCR downstream signaling—IL3—Crohn's disease	6.4e-05	0.00285	CbGpPWpGaD
Metoclopramide—HTR4—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	6.4e-05	0.00285	CbGpPWpGaD
Metoclopramide—DRD3—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	6.38e-05	0.00284	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—CCR9—Crohn's disease	6.38e-05	0.00284	CbGpPWpGaD
Metoclopramide—CYP2D6—Metapathway biotransformation—GPX4—Crohn's disease	6.36e-05	0.00283	CbGpPWpGaD
Metoclopramide—Nausea—Azathioprine—Crohn's disease	6.36e-05	0.00576	CcSEcCtD
Metoclopramide—CHRM1—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	6.34e-05	0.00282	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—CCR9—Crohn's disease	6.24e-05	0.00278	CbGpPWpGaD
Metoclopramide—HTR4—GPCR downstream signaling—RASGRP1—Crohn's disease	6.19e-05	0.00276	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—MLN—Crohn's disease	6.17e-05	0.00274	CbGpPWpGaD
Metoclopramide—Rash—Mesalazine—Crohn's disease	6.15e-05	0.00557	CcSEcCtD
Metoclopramide—Dermatitis—Mesalazine—Crohn's disease	6.15e-05	0.00556	CcSEcCtD
Metoclopramide—Headache—Mesalazine—Crohn's disease	6.11e-05	0.00553	CcSEcCtD
Metoclopramide—CYP11B1—Metabolism—MTMR3—Crohn's disease	5.98e-05	0.00266	CbGpPWpGaD
Metoclopramide—CHRM1—G alpha (q) signalling events—RASGRP1—Crohn's disease	5.94e-05	0.00264	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—GPR65—Crohn's disease	5.93e-05	0.00264	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—IL3—Crohn's disease	5.82e-05	0.00259	CbGpPWpGaD
Metoclopramide—Agitation—Prednisone—Crohn's disease	5.81e-05	0.00526	CcSEcCtD
Metoclopramide—CHRM1—GPCR ligand binding—GPR65—Crohn's disease	5.8e-05	0.00258	CbGpPWpGaD
Metoclopramide—Nausea—Mesalazine—Crohn's disease	5.8e-05	0.00524	CcSEcCtD
Metoclopramide—Angioedema—Prednisone—Crohn's disease	5.78e-05	0.00523	CcSEcCtD
Metoclopramide—DRD2—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	5.7e-05	0.00254	CbGpPWpGaD
Metoclopramide—HTR3A—SIDS Susceptibility Pathways—TNF—Crohn's disease	5.69e-05	0.00253	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—RASGRP1—Crohn's disease	5.63e-05	0.0025	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—MTMR3—Crohn's disease	5.59e-05	0.00249	CbGpPWpGaD
Metoclopramide—CHRM1—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	5.58e-05	0.00248	CbGpPWpGaD
Metoclopramide—DRD2—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	5.55e-05	0.00247	CbGpPWpGaD
Metoclopramide—DRD3—GPCR ligand binding—CCR6—Crohn's disease	5.52e-05	0.00246	CbGpPWpGaD
Metoclopramide—Convulsion—Prednisone—Crohn's disease	5.48e-05	0.00496	CcSEcCtD
Metoclopramide—Hypertension—Prednisone—Crohn's disease	5.46e-05	0.00494	CcSEcCtD
Metoclopramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	5.43e-05	0.00241	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—FADS1—Crohn's disease	5.41e-05	0.00241	CbGpPWpGaD
Metoclopramide—Anxiety—Prednisone—Crohn's disease	5.37e-05	0.00486	CcSEcCtD
Metoclopramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—Crohn's disease	5.32e-05	0.00237	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—MLN—Crohn's disease	5.2e-05	0.00231	CbGpPWpGaD
Metoclopramide—Oedema—Prednisone—Crohn's disease	5.16e-05	0.00467	CcSEcCtD
Metoclopramide—CHRM1—GPCR downstream signaling—MLN—Crohn's disease	5.09e-05	0.00226	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—GPX4—Crohn's disease	5.06e-05	0.00225	CbGpPWpGaD
Metoclopramide—Tachycardia—Prednisone—Crohn's disease	5.04e-05	0.00456	CcSEcCtD
Metoclopramide—DRD2—Signaling by GPCR—ACKR2—Crohn's disease	4.98e-05	0.00222	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—GCKR—Crohn's disease	4.89e-05	0.00218	CbGpPWpGaD
Metoclopramide—DRD2—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	4.88e-05	0.00217	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—ACKR2—Crohn's disease	4.87e-05	0.00217	CbGpPWpGaD
Metoclopramide—HTR4—GPCR ligand binding—CXCL8—Crohn's disease	4.87e-05	0.00217	CbGpPWpGaD
Metoclopramide—DRD3—GPCR ligand binding—PTGER4—Crohn's disease	4.86e-05	0.00216	CbGpPWpGaD
Metoclopramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	4.78e-05	0.00213	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—MLN—Crohn's disease	4.72e-05	0.0021	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—CCR9—Crohn's disease	4.71e-05	0.00209	CbGpPWpGaD
Metoclopramide—Insomnia—Prednisone—Crohn's disease	4.67e-05	0.00422	CcSEcCtD
Metoclopramide—CYP11B1—Metabolism—FADS1—Crohn's disease	4.66e-05	0.00207	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—MLN—Crohn's disease	4.62e-05	0.00206	CbGpPWpGaD
Metoclopramide—HTR3A—SIDS Susceptibility Pathways—IL6—Crohn's disease	4.59e-05	0.00204	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—CCR6—Crohn's disease	4.58e-05	0.00204	CbGpPWpGaD
Metoclopramide—HTR4—GPCR downstream signaling—IL2RA—Crohn's disease	4.49e-05	0.002	CbGpPWpGaD
Metoclopramide—Fatigue—Prednisone—Crohn's disease	4.45e-05	0.00403	CcSEcCtD
Metoclopramide—DRD3—GPCR downstream signaling—GPR65—Crohn's disease	4.38e-05	0.00195	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—GPX4—Crohn's disease	4.36e-05	0.00194	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—FADS1—Crohn's disease	4.36e-05	0.00194	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—CCR9—Crohn's disease	4.28e-05	0.0019	CbGpPWpGaD
Metoclopramide—Feeling abnormal—Prednisone—Crohn's disease	4.25e-05	0.00385	CcSEcCtD
Metoclopramide—DRD2—GPCR ligand binding—CCR6—Crohn's disease	4.22e-05	0.00188	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—GCKR—Crohn's disease	4.21e-05	0.00187	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—RBX1—Crohn's disease	4.14e-05	0.00184	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—CCR6—Crohn's disease	4.13e-05	0.00184	CbGpPWpGaD
Metoclopramide—Urticaria—Prednisone—Crohn's disease	4.1e-05	0.00371	CcSEcCtD
Metoclopramide—Body temperature increased—Prednisone—Crohn's disease	4.08e-05	0.00369	CcSEcCtD
Metoclopramide—CYP17A1—Metabolism—GPX4—Crohn's disease	4.08e-05	0.00182	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—IL2RA—Crohn's disease	4.07e-05	0.00181	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—PTGER4—Crohn's disease	4.03e-05	0.00179	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—GPR65—Crohn's disease	3.97e-05	0.00177	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—GCKR—Crohn's disease	3.94e-05	0.00175	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—ACKR2—Crohn's disease	3.84e-05	0.00171	CbGpPWpGaD
Metoclopramide—Hypersensitivity—Prednisone—Crohn's disease	3.8e-05	0.00344	CcSEcCtD
Metoclopramide—DRD2—GPCR ligand binding—PTGER4—Crohn's disease	3.72e-05	0.00165	CbGpPWpGaD
Metoclopramide—Asthenia—Prednisone—Crohn's disease	3.7e-05	0.00335	CcSEcCtD
Metoclopramide—DRD3—Signaling Pathways—MLN—Crohn's disease	3.64e-05	0.00162	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—PTGER4—Crohn's disease	3.64e-05	0.00162	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—UBE2D1—Crohn's disease	3.63e-05	0.00162	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—CCR9—Crohn's disease	3.6e-05	0.0016	CbGpPWpGaD
Metoclopramide—Diarrhoea—Prednisone—Crohn's disease	3.53e-05	0.0032	CcSEcCtD
Metoclopramide—CHRM1—GPCR downstream signaling—CCR9—Crohn's disease	3.53e-05	0.00157	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—RIPK2—Crohn's disease	3.52e-05	0.00157	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	3.49e-05	0.00155	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—IL3—Crohn's disease	3.44e-05	0.00153	CbGpPWpGaD
Metoclopramide—Dizziness—Prednisone—Crohn's disease	3.41e-05	0.00309	CcSEcCtD
Metoclopramide—DRD2—GPCR downstream signaling—GPR65—Crohn's disease	3.35e-05	0.00149	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—TAGAP—Crohn's disease	3.33e-05	0.00148	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—RASGRP1—Crohn's disease	3.32e-05	0.00148	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—GPR65—Crohn's disease	3.28e-05	0.00146	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—CCR9—Crohn's disease	3.27e-05	0.00146	CbGpPWpGaD
Metoclopramide—Rash—Prednisone—Crohn's disease	3.26e-05	0.00295	CcSEcCtD
Metoclopramide—Dermatitis—Prednisone—Crohn's disease	3.25e-05	0.00294	CcSEcCtD
Metoclopramide—HTR3A—Transmembrane transport of small molecules—ALB—Crohn's disease	3.25e-05	0.00145	CbGpPWpGaD
Metoclopramide—Headache—Prednisone—Crohn's disease	3.23e-05	0.00293	CcSEcCtD
Metoclopramide—CHRM1—Signaling by GPCR—CCR9—Crohn's disease	3.2e-05	0.00142	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—CCR6—Crohn's disease	3.12e-05	0.00139	CbGpPWpGaD
Metoclopramide—Nausea—Prednisone—Crohn's disease	3.07e-05	0.00277	CcSEcCtD
Metoclopramide—CYP11B2—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	3.06e-05	0.00136	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—GPR65—Crohn's disease	3.04e-05	0.00135	CbGpPWpGaD
Metoclopramide—HTR4—GPCR downstream signaling—JAK2—Crohn's disease	3.02e-05	0.00134	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	3.01e-05	0.00134	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—SOCS1—Crohn's disease	3.01e-05	0.00134	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—GPR65—Crohn's disease	2.98e-05	0.00132	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—ACKR2—Crohn's disease	2.94e-05	0.00131	CbGpPWpGaD
Metoclopramide—DRD3—G alpha (i) signalling events—CXCL8—Crohn's disease	2.94e-05	0.00131	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—RSPO3—Crohn's disease	2.91e-05	0.0013	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—ACKR2—Crohn's disease	2.88e-05	0.00128	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—TYK2—Crohn's disease	2.87e-05	0.00128	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—CCR6—Crohn's disease	2.83e-05	0.00126	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	2.82e-05	0.00125	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—MLN—Crohn's disease	2.79e-05	0.00124	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—SEL1L—Crohn's disease	2.76e-05	0.00123	CbGpPWpGaD
Metoclopramide—HTR4—GPCR downstream signaling—CXCL8—Crohn's disease	2.75e-05	0.00122	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—PTGER4—Crohn's disease	2.75e-05	0.00122	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—JAK2—Crohn's disease	2.74e-05	0.00122	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—MLN—Crohn's disease	2.73e-05	0.00121	CbGpPWpGaD
Metoclopramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	2.71e-05	0.00121	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	2.63e-05	0.00117	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—SMAD3—Crohn's disease	2.6e-05	0.00116	CbGpPWpGaD
Metoclopramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	2.59e-05	0.00115	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—TAGAP—Crohn's disease	2.55e-05	0.00113	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CCR9—Crohn's disease	2.53e-05	0.00112	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—CXCL8—Crohn's disease	2.5e-05	0.00111	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—TAGAP—Crohn's disease	2.5e-05	0.00111	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—PTGER4—Crohn's disease	2.49e-05	0.00111	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	2.46e-05	0.0011	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—IL2RA—Crohn's disease	2.41e-05	0.00107	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—CCR6—Crohn's disease	2.39e-05	0.00106	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—GPR65—Crohn's disease	2.35e-05	0.00104	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—IL3—Crohn's disease	2.34e-05	0.00104	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—CCR6—Crohn's disease	2.34e-05	0.00104	CbGpPWpGaD
Metoclopramide—DRD3—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	2.34e-05	0.00104	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—RASGRP1—Crohn's disease	2.26e-05	0.00101	CbGpPWpGaD
Metoclopramide—DRD2—G alpha (i) signalling events—CXCL8—Crohn's disease	2.25e-05	0.001	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—RSPO3—Crohn's disease	2.23e-05	0.000992	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—RSPO3—Crohn's disease	2.18e-05	0.000971	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—CCR6—Crohn's disease	2.17e-05	0.000964	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—IL3—Crohn's disease	2.12e-05	0.000945	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—CCR6—Crohn's disease	2.12e-05	0.000944	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—SEL1L—Crohn's disease	2.11e-05	0.00094	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—PTGER4—Crohn's disease	2.1e-05	0.000935	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—SEL1L—Crohn's disease	2.07e-05	0.00092	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—PTGER4—Crohn's disease	2.06e-05	0.000915	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—RASGRP1—Crohn's disease	2.05e-05	0.000914	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CCR9—Crohn's disease	1.93e-05	0.00086	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—PTGER4—Crohn's disease	1.91e-05	0.000849	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CCR9—Crohn's disease	1.89e-05	0.000842	CbGpPWpGaD
Metoclopramide—DRD3—Circadian rythm related genes—IL6—Crohn's disease	1.87e-05	0.000832	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—PTGER4—Crohn's disease	1.87e-05	0.000831	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—GPR65—Crohn's disease	1.8e-05	0.000799	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—IL3—Crohn's disease	1.79e-05	0.000796	CbGpPWpGaD
Metoclopramide—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	1.79e-05	0.000795	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—PLA2G4F—Crohn's disease	1.78e-05	0.000792	CbGpPWpGaD
Metoclopramide—DRD3—GPCR ligand binding—CXCL8—Crohn's disease	1.78e-05	0.000791	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—GPR65—Crohn's disease	1.76e-05	0.000782	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—IL3—Crohn's disease	1.75e-05	0.000779	CbGpPWpGaD
Metoclopramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	1.75e-05	0.000778	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—RASGRP1—Crohn's disease	1.73e-05	0.00077	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—TYK2—Crohn's disease	1.7e-05	0.000754	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—RASGRP1—Crohn's disease	1.69e-05	0.000754	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CCR6—Crohn's disease	1.67e-05	0.000744	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—IL2RA—Crohn's disease	1.64e-05	0.000729	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—IL3—Crohn's disease	1.63e-05	0.000723	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—JAK2—Crohn's disease	1.62e-05	0.00072	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—IL3—Crohn's disease	1.59e-05	0.000708	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—RASGRP1—Crohn's disease	1.57e-05	0.000699	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—ALB—Crohn's disease	1.56e-05	0.000692	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—RASGRP1—Crohn's disease	1.54e-05	0.000684	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—RBX1—Crohn's disease	1.51e-05	0.000673	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—MTMR3—Crohn's disease	1.51e-05	0.000673	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—IL2RA—Crohn's disease	1.49e-05	0.000662	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—CXCL8—Crohn's disease	1.48e-05	0.000657	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—PTGER4—Crohn's disease	1.47e-05	0.000655	CbGpPWpGaD
Metoclopramide—DRD2—Circadian rythm related genes—IL6—Crohn's disease	1.43e-05	0.000637	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—IL6—Crohn's disease	1.4e-05	0.000625	CbGpPWpGaD
Metoclopramide—CHRM1—Circadian rythm related genes—IL6—Crohn's disease	1.4e-05	0.000623	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—PTGS2—Crohn's disease	1.36e-05	0.000606	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—CXCL8—Crohn's disease	1.36e-05	0.000605	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—ALB—Crohn's disease	1.34e-05	0.000597	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—CXCL8—Crohn's disease	1.33e-05	0.000593	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—UBE2D1—Crohn's disease	1.33e-05	0.00059	CbGpPWpGaD
Metoclopramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	1.33e-05	0.00059	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—RIPK2—Crohn's disease	1.29e-05	0.000572	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CCR6—Crohn's disease	1.28e-05	0.00057	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—IL3—Crohn's disease	1.25e-05	0.000558	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—ALB—Crohn's disease	1.25e-05	0.000558	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—IL2RA—Crohn's disease	1.25e-05	0.000558	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CCR6—Crohn's disease	1.25e-05	0.000557	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—IL2RA—Crohn's disease	1.23e-05	0.000546	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—RASGRP1—Crohn's disease	1.21e-05	0.00054	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—STAT3—Crohn's disease	1.19e-05	0.000528	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—FADS1—Crohn's disease	1.18e-05	0.000524	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—PTGS2—Crohn's disease	1.17e-05	0.000522	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—RBX1—Crohn's disease	1.16e-05	0.000515	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—IL2RA—Crohn's disease	1.14e-05	0.000507	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—RBX1—Crohn's disease	1.13e-05	0.000504	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—PTGER4—Crohn's disease	1.13e-05	0.000502	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—IL2RA—Crohn's disease	1.11e-05	0.000496	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—GPX4—Crohn's disease	1.1e-05	0.000491	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—PTGER4—Crohn's disease	1.1e-05	0.000491	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—JAK2—Crohn's disease	1.1e-05	0.00049	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—SOCS1—Crohn's disease	1.1e-05	0.000489	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—PTGS2—Crohn's disease	1.1e-05	0.000488	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—GCKR—Crohn's disease	1.07e-05	0.000474	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—TYK2—Crohn's disease	1.05e-05	0.000466	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—UBE2D1—Crohn's disease	1.02e-05	0.000452	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—CXCL8—Crohn's disease	1.01e-05	0.000447	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—JAK2—Crohn's disease	1e-05	0.000445	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—UBE2D1—Crohn's disease	9.94e-06	0.000442	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—RIPK2—Crohn's disease	9.85e-06	0.000438	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—RIPK2—Crohn's disease	9.64e-06	0.000429	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—IL3—Crohn's disease	9.6e-06	0.000427	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—SMAD3—Crohn's disease	9.49e-06	0.000422	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—IL3—Crohn's disease	9.4e-06	0.000418	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—RASGRP1—Crohn's disease	9.29e-06	0.000413	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—CXCL8—Crohn's disease	9.13e-06	0.000406	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—RASGRP1—Crohn's disease	9.09e-06	0.000404	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—IL2RA—Crohn's disease	8.79e-06	0.000391	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—JAK2—Crohn's disease	8.43e-06	0.000375	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—SOCS1—Crohn's disease	8.41e-06	0.000374	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—IL6—Crohn's disease	8.29e-06	0.000369	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—JAK2—Crohn's disease	8.25e-06	0.000367	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—SOCS1—Crohn's disease	8.23e-06	0.000366	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—TYK2—Crohn's disease	8.02e-06	0.000357	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—TYK2—Crohn's disease	7.85e-06	0.000349	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—CXCL8—Crohn's disease	7.69e-06	0.000342	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—JAK2—Crohn's disease	7.65e-06	0.00034	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—CXCL8—Crohn's disease	7.53e-06	0.000335	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—JAK2—Crohn's disease	7.49e-06	0.000333	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—SMAD3—Crohn's disease	7.26e-06	0.000323	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—SMAD3—Crohn's disease	7.11e-06	0.000316	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—CXCL8—Crohn's disease	6.98e-06	0.000311	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—CXCL8—Crohn's disease	6.84e-06	0.000304	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—IL2RA—Crohn's disease	6.73e-06	0.000299	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—IL2RA—Crohn's disease	6.58e-06	0.000293	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—TYK2—Crohn's disease	6.19e-06	0.000276	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—JAK2—Crohn's disease	5.91e-06	0.000263	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CXCL8—Crohn's disease	5.39e-06	0.00024	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—IL6—Crohn's disease	5.13e-06	0.000228	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—TYK2—Crohn's disease	4.74e-06	0.000211	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—TYK2—Crohn's disease	4.64e-06	0.000206	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—JAK2—Crohn's disease	4.52e-06	0.000201	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—JAK2—Crohn's disease	4.42e-06	0.000197	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—STAT3—Crohn's disease	4.34e-06	0.000193	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CXCL8—Crohn's disease	4.13e-06	0.000184	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CXCL8—Crohn's disease	4.04e-06	0.00018	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—IL6—Crohn's disease	3.92e-06	0.000175	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—IL6—Crohn's disease	3.84e-06	0.000171	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—ALB—Crohn's disease	3.39e-06	0.000151	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—STAT3—Crohn's disease	3.32e-06	0.000148	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—STAT3—Crohn's disease	3.25e-06	0.000144	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—IL6—Crohn's disease	3.03e-06	0.000135	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—PTGS2—Crohn's disease	2.97e-06	0.000132	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—IL6—Crohn's disease	2.32e-06	0.000103	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—IL6—Crohn's disease	2.27e-06	0.000101	CbGpPWpGaD
